System |
Count |
Percentage |
Central nervous
system |
68 |
35.6% |
Musculoskeletal
system |
45 |
23.6% |
Genitourinary system |
36 |
18.8% |
Cardiovascular system |
10 |
5.2% |
Gastrointestinal
system |
8 |
4.2% |
Syndromes |
8 |
4.2% |
Miscellaneous |
16 |
8.4% |
Total |
191 |
100 |
System |
Total
cases |
Cases
detected by ultrasound |
Percentage |
Central nervous
system |
68 |
55 |
80.88% |
Musculoskeletal |
45 |
27 |
60% |
Genitourinary |
36 |
24 |
66.67% |
Cardiovascular |
10 |
6 |
60% |
Gastrointestinal |
8 |
4 |
50% |
Syndromes |
8 |
3 |
37.50% |
Miscellaneous |
16 |
9 |
56.25% |
System |
<18
Weeks |
18-20
Weeks |
>20
Weeks |
Central nervous
system |
2 |
4 |
49 |
Musculoskeletal |
12 |
0 |
15 |
Genitourinary |
0 |
10 |
14 |
Cardiovascular |
0 |
0 |
6 |
Gastrointestinal |
0 |
0 |
4 |
Syndromes |
0 |
0 |
3 |
Miscellaneous |
0 |
0 |
9 |
Total |
14(10.93%) |
14(10.93%) |
100(78.13%) |
Family
history of anomaly |
Cases |
Controls |
Present |
16(8.4%) |
0(0%) |
Absent |
175(91.6%0 |
191(100%) |
Total |
191(100%) |
191(100%) |
History
of previous anomalous pregnancy |
Cases |
Controls |
Present |
12(6.3%) |
4(2.1%) |
Absent |
179(93.7%) |
187(97.9%) |
Total |
191(100%) |
191(100%) |
Periconceptional
folic acid intake |
Cases |
Controls |
Present |
131(68.6%) |
71(37.2%) |
Absent |
60(31.4%) |
120(62.8%) |
Total |
191(100%) |
191(100%) |
Maternal
diabetes |
Cases |
Controls |
Present |
62(32.5%) |
10(5.2%) |
Absent |
129(67.5%) |
181(94.8%) |
Total |
191(100%) |
191(100%) |
Maternal
epilepsy |
Cases |
Controls |
Present |
9(4.7%) |
1(0.5%) |
Absent |
182(95.3%) |
190(99.5%) |
Total |
191(100%) |
191(100%) |
Factor |
Cases |
Percentage |
Maternal age >25 yrs |
105 |
55 |
Referred |
130 |
68.1 |
Presence of consanguinity |
30 |
15.7 |
Presence of maternal history of infertility |
31 |
16.2 |
Presence of family history of anomaly |
16 |
8.4 |
Presence of maternal history of previous adverse
pregnancy outcome |
46 |
24.1 |
Absence of periconceptional folic acid |
131 |
68.6 |
Presence of drug intake in first trimester |
9 |
4.7 |
Presence of maternal diabetes |
62 |
32.5 |
Presence of maternal epilepsy |
9 |
4.7 |
Presence of maternal spotting PV |
52 |
27.2 |
Presence of IUGR |
116 |
60.7 |
Presence of oligamnios |
43 |
22.5 |
Presence of hydramnios |
61 |
31.9 |
Male fetus |
133 |
69.6 |